| Successful pregnancy after busulfan/cytoxan conditioning regimen for AML. | |
| | |
MedLine Citation:
|
PMID: 21694553 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The number of patients who have had successful pregnancies following hematopoietic stem cell transplant during childhood remains under investigation. As the number of survivors increase and enter adulthood, we continue to learn more about fertility in these patients. In this case report we report the case of a 27 year-old female who had a normal full term delivery 19 years following a myeloablative autologous transplant for relapsed acute myelogenous leukemia. |
| | |
Authors:
|
Ami J Shah |
Related Documents
:
|
10390113 - Acog practice bulletin. medical management of tubal pregnancy. number 3, december 1998.... 1916493 - Appropriateness of cholecystectomy in the united kingdom--a consensus panel approach. 14510343 - Thyroid function tests in pregnancy. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Journal of pediatric hematology/oncology Volume: 33 ISSN: 1536-3678 ISO Abbreviation: J. Pediatr. Hematol. Oncol. Publication Date: 2011 Jul |
Date Detail:
|
Created Date: 2011-06-22 Completed Date: 2011-09-01 Revised Date: 2011-10-06 |
Medline Journal Info:
|
Nlm Unique ID: 9505928 Medline TA: J Pediatr Hematol Oncol Country: United States |
Other Details:
|
Languages: eng Pagination: e180-1 Citation Subset: IM |
Affiliation:
|
Division of Research Immunology/Bone Marrow Transplantation, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA. Ashah@chla.usc.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Busulfan / therapeutic use* Child Cyclophosphamide / therapeutic use* Female Hematopoietic Stem Cell Transplantation* Humans Leukemia, Myeloid, Acute / therapy* Myeloablative Agonists / therapeutic use Pregnancy Pregnancy Outcome* Recurrence Time Factors Transplantation Conditioning / methods* |
| Chemical | |
Reg. No./Substance:
|
0/Myeloablative Agonists; 50-18-0/Cyclophosphamide; 55-98-1/Busulfan |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Measurement of mucosal conductivity by MII is a potential marker of mucosal integrity restored in in...
Next Document: A retrospective study of malaria in pediatric oncology patients in Senegal.